787 related articles for article (PubMed ID: 29888440)
1. Kawasaki disease shock syndrome: Unique and severe subtype of Kawasaki disease.
Gamez-Gonzalez LB; Moribe-Quintero I; Cisneros-Castolo M; Varela-Ortiz J; Muñoz-Ramírez M; Garrido-García M; Yamazaki-Nakashimada M
Pediatr Int; 2018 Sep; 60(9):781-790. PubMed ID: 29888440
[TBL] [Abstract][Full Text] [Related]
2. Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition.
Li Y; Zheng Q; Zou L; Wu J; Guo L; Teng L; Zheng R; Jung LKL; Lu M
Pediatr Rheumatol Online J; 2019 Jan; 17(1):1. PubMed ID: 30611297
[TBL] [Abstract][Full Text] [Related]
3. Clinical manifestations associated with Kawasaki disease shock syndrome in Mexican children.
Gámez-González LB; Murata C; Muñoz-Ramírez M; Yamazaki-Nakashimada M
Eur J Pediatr; 2013 Mar; 172(3):337-42. PubMed ID: 23152158
[TBL] [Abstract][Full Text] [Related]
4. Clinical manifestations of Kawasaki disease shock syndrome: a case-control study.
Chen PS; Chi H; Huang FY; Peng CC; Chen MR; Chiu NC
J Microbiol Immunol Infect; 2015 Feb; 48(1):43-50. PubMed ID: 23927822
[TBL] [Abstract][Full Text] [Related]
5. Clinical Manifestations of Kawasaki Disease Shock Syndrome.
Ma L; Zhang YY; Yu HG
Clin Pediatr (Phila); 2018 Apr; 57(4):428-435. PubMed ID: 28905639
[TBL] [Abstract][Full Text] [Related]
6. Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey.
Cattalini M; Della Paolera S; Zunica F; Bracaglia C; Giangreco M; Verdoni L; Meini A; Sottile R; Caorsi R; Zuccotti G; Fabi M; Montin D; Meneghel A; Consolaro A; Dellepiane RM; Maggio MC; La Torre F; Marchesi A; Simonini G; Villani A; Cimaz R; Ravelli A; Taddio A;
Pediatr Rheumatol Online J; 2021 Mar; 19(1):29. PubMed ID: 33726806
[TBL] [Abstract][Full Text] [Related]
7. Shock and unresponsiveness to repeated courses of intravenous immunoglobulin in Kawasaki disease: a nationwide database study.
Liang YC; Chang CH; Lin MT; Kao FY; Huang SK; Wu MH
Pediatr Res; 2020 Apr; 87(5):961-966. PubMed ID: 31711068
[TBL] [Abstract][Full Text] [Related]
8. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
Yılmazer MM; Özdemir R; Meşe T; Küçük M; Öner T; Devrim İ; Bayram N; Güven B; Tavlı V
Turk J Pediatr; 2019; 61(5):648-656. PubMed ID: 32104995
[TBL] [Abstract][Full Text] [Related]
9. Clinical aspects for differential diagnosis of Kawasaki disease shock syndrome: a case control study.
Park WY; Lee SY; Kim GB; Song MK; Kwon HW; Bae EJ; Choi EH; Park JD
BMC Pediatr; 2021 Jan; 21(1):25. PubMed ID: 33413220
[TBL] [Abstract][Full Text] [Related]
10. Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children.
Chen MR; Kuo HC; Lee YJ; Chi H; Li SC; Lee HC; Yang KD
Front Immunol; 2021; 12():632890. PubMed ID: 33732254
[TBL] [Abstract][Full Text] [Related]
11. Predictors of intravenous immunoglobulin resistance and coronary artery aneurysm in patients with Kawasaki disease.
Chantasiriwan N; Silvilairat S; Makonkawkeyoon K; Pongprot Y; Sittiwangkul R
Paediatr Int Child Health; 2018 Aug; 38(3):209-212. PubMed ID: 29768976
[TBL] [Abstract][Full Text] [Related]
12. Describing Kawasaki shock syndrome: results from a retrospective study and literature review.
Taddio A; Rossi ED; Monasta L; Pastore S; Tommasini A; Lepore L; Bronzetti G; Marrani E; Mottolese BD; Simonini G; Cimaz R; Ventura A
Clin Rheumatol; 2017 Jan; 36(1):223-228. PubMed ID: 27230223
[TBL] [Abstract][Full Text] [Related]
13. Kawasaki disease shock syndrome: case report.
Yang HF; Chen WL; Chang CN; Chen SJ; Fan HC
Paediatr Int Child Health; 2016 Feb; 36(1):76-8. PubMed ID: 25695906
[TBL] [Abstract][Full Text] [Related]
14. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?
Jone PN; Anderson MS; Mulvahill MJ; Heizer H; Glodé MP; Dominguez SR
Pediatr Infect Dis J; 2018 Oct; 37(10):976-980. PubMed ID: 29461447
[TBL] [Abstract][Full Text] [Related]
15. Early Differentiation of Kawasaki Disease Shock Syndrome and Toxic Shock Syndrome in a Pediatric Intensive Care Unit.
Lin YJ; Cheng MC; Lo MH; Chien SJ
Pediatr Infect Dis J; 2015 Nov; 34(11):1163-7. PubMed ID: 26222065
[TBL] [Abstract][Full Text] [Related]
16. Kawasaki disease: a comprehensive review of treatment options.
Patel RM; Shulman ST
J Clin Pharm Ther; 2015 Dec; 40(6):620-5. PubMed ID: 26547265
[TBL] [Abstract][Full Text] [Related]
17. Risk factors of immunoglobulin resistance and coronary complications in children with Kawasaki disease.
Berdej-Szczot E; Małecka-Tendera E; Gawlik T; Firek-Pędras M; Szydłowski L; Gawlik A
Kardiol Pol; 2017; 75(3):261-266. PubMed ID: 27995598
[TBL] [Abstract][Full Text] [Related]
18. Kawasaki disease in Sicily: clinical description and markers of disease severity.
Maggio MC; Corsello G; Prinzi E; Cimaz R
Ital J Pediatr; 2016 Nov; 42(1):92. PubMed ID: 27806720
[TBL] [Abstract][Full Text] [Related]
19. Kawasaki disease with severe cardiac sequelae: lessons from recent New Zealand experience.
Wilson N; Heaton P; Calder L; Nicholson R; Stables S; Gavin R
J Paediatr Child Health; 2004; 40(9-10):524-9. PubMed ID: 15367145
[TBL] [Abstract][Full Text] [Related]
20. High neutrophil : lymphocyte ratio is associated with refractory Kawasaki disease.
Cho HJ; Bak SY; Kim SY; Yoo R; Baek HS; Yang S; Hwang IT; Ban JE
Pediatr Int; 2017 Jun; 59(6):669-674. PubMed ID: 28097746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
